Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00752_DB00953_nanopub.RAh0i_Xmn9qUvmAKWecGF9BkoA992qch5HRC0VrfAAeqI#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00752_DB00953 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00752_DB00953 label "DDI between Tranylcypromine and Rizatriptan - The MAO inhibitor, Tranylcypromine, may reduce the metabolism and clearance of the serotonin 5-HT1D receptor agonist, Rizatriptan. Risk of serotonin syndrome and Rizatriptan toxicity. Concomitant therapy should be avoided. [drugbank_resource:DB00752_DB00953]" assertion.
- drugbank_resource:DB00752_DB00953 identifier "drugbank_resource:DB00752_DB00953" assertion.
- drugbank_resource:DB00752_DB00953 title "DDI between Tranylcypromine and Rizatriptan - The MAO inhibitor, Tranylcypromine, may reduce the metabolism and clearance of the serotonin 5-HT1D receptor agonist, Rizatriptan. Risk of serotonin syndrome and Rizatriptan toxicity. Concomitant therapy should be avoided." assertion.
- drugbank:DB00953 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00752_DB00953 assertion.
- drugbank:DB00752 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00752_DB00953 assertion.